Loading insider details...
Latest Form 4 (Feb 20, 2026): Grant/Award of 85,000 TRVI shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 20, 2026 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 85,000 | n/a |
| Jun 3, 2025 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 60,000 | n/a |
| Mar 26, 2025 | Trevi Therapeutics, Inc. (TRVI) | Exercise/Conversion | 2,631 | $3.8K |
| Mar 12, 2025 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 32,000 | n/a |
| Feb 20, 2025 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 116,000 | n/a |
| Aug 21, 2024 | Trevi Therapeutics, Inc. (TRVI) | Exercise/Conversion | 16,496 | $23.6K |
| Aug 16, 2024 | Trevi Therapeutics, Inc. (TRVI) | Exercise/Conversion | 100 | $143.00 |
| May 31, 2024 | Trevi Therapeutics, Inc. (TRVI) | Exercise/Conversion | 59,354 | $130.0K |
| Feb 16, 2024 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 150,000 | n/a |
| Feb 16, 2023 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 187,500 | n/a |